Variable Patterns of Response to Rituximab Treatment in Adults With Chronic Idiopathic Thrombocytopenic Purpura

Blood - United States
doi 10.1182/blood-2002-02-0392
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society of Hematology

Related search

Lower Dose Rituximab Is Active in Adults Patients With Idiopathic Thrombocytopenic Purpura

Haematologica
Hematology
2008English

Morbidity and Mortality in Adults With Idiopathic Thrombocytopenic Purpura

Blood
BiochemistryImmunologyCell BiologyHematology
2001English

Therapeutic Effects of Rituximab Combined With Cyclophosphamide on Refractory Idiopathic Thrombocytopenic Purpura

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2019English

Cost-Effectiveness of Adding Rituximab to Splenectomy and Romiplostim for Treating Steroid-Resistant Idiopathic Thrombocytopenic Purpura in Adults

BMC Health Services Research
Health Policy
2015English

Idiopathic Thrombocytopenic Purpura

Current Paediatrics
1995English

PP025 Thrombopoietin Receptor Agonist for Treatment of Adults With Chronic Immune Thrombocytopenic Purpura

International Journal of Technology Assessment in Health Care
Health Policy
2017English

A Case of Aortic Valve Replacement in Patient With Chronic Idiopathic Thrombocytopenic Purpura.

Japanese Journal of Cardiovascular Surgery
2000English

Relapsing or Refractory Idiopathic Thrombotic Thrombocytopenic Purpura-Hemolytic Uremic Syndrome: The Role of Rituximab

Transfusion
AllergyImmunologyHematology
2010English

A Case of Invasive Treatment in Idiopathic Thrombocytopenic Purpura During Pregnancy

Japanese Journal of Oral Diagnosis / Oral Medicine
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy